You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IgG4-RD Responder Index (IgG4-RD RI)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)

Not yet recruiting
  • Autoimmune Diseases
  • placebo
  • mycophenolate mofetil
  • Beijing, China
    Peking Union Medical College Hospital
Jul 26, 2023

IgG4 Related Disease, IgG4-RD Trial in Atlanta, Boston, Rochester (elotuzumab, for elotuzumab, methylprednisolone)

Recruiting
  • IgG4 Related Disease
  • IgG4-RD
  • Atlanta, Georgia
  • +2 more
Jul 13, 2022

Autoimmune Diseases Trial in Beijing (Diprospan plus iguratimod, Diprospan plus leflunomide, Prednisone plus leflunomide)

Recruiting
  • Autoimmune Diseases
  • Diprospan plus iguratimod
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

Autoimmune Diseases Trial in Beijing (Prednisone and Mycophenolate Mofetil, Mycophenolate Mofetil, Leflunomide)

Recruiting
  • Autoimmune Diseases
  • Prednisone and Mycophenolate Mofetil
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

Recruiting
  • IgG4-related Disease With Eosinophilia
  • Beijing, Bejing, China
    Peking Union Medical College Hospital
Mar 23, 2023

IgG4-related Disease Trial in Beijing (68Ga-FAPI)

Recruiting
  • IgG4-related Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 24, 2021

Plasmablast/Plasma Cells in Diagnosis of IgG4-RD, Plasmablast/Plasma Cells in Relapse Prediction of IgG4-RD Trial in Beijing

Unknown status
  • Plasmablast/Plasma Cells in Diagnosis of IgG4-RD
  • Plasmablast/Plasma Cells in Relapse Prediction of IgG4-RD
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 1, 2020

    IgG4-related Disease Trial (Sirolimus)

    Not yet recruiting
    • IgG4-related Disease
    • (no location specified)
    Feb 25, 2023

    IgG4 Related Disease Trial in United States (Obexelimab, Placebo)

    Recruiting
    • IgG4 Related Disease
    • Walnut Creek, California
    • +3 more
    Jan 27, 2023

    IgG4 Related Disease Trial in Worldwide (Inebilizumab, Placebo)

    Recruiting
    • IgG4 Related Disease
    • Palo Alto, California
    • +81 more
    Oct 19, 2022

    IgG4-related Disease Trial in Boston (Abatacept)

    Completed
    Has Results
    • IgG4-related Disease
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 30, 2021

    Tofatib Treatment for IgG4-related Disease

    Recruiting
    • IgG4-related Disease
    • Shanghai, Shanghai, China
      Shanghai Changhai Hospital
    Nov 15, 2022

    Autoimmune Diseases Trial in Beijing (Drug free, IS monotherapy and GC combined with IS)

    Recruiting
    • Autoimmune Diseases
    • Drug free, IS monotherapy and GC combined with IS
    • Beijing, Beijing, China
      Beijing Friendship Hospital
    Jan 21, 2022

    Detecting IgG4-related Sclerosing Cholangitis

    Completed
    • IgG4-related Sclerosing Cholangitis
    • IgG4-related Disease
      • Rochester, Minnesota
      • +1 more
      Jan 3, 2022

      IgG4-related Disease Trial in Beijing (Prednisone and Belimumab, Prednisone)

      Recruiting
      • IgG4-related Disease
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jan 6, 2021

      Diagnostic and Prognostic Biomarkers for IgG4-related Disease.

      Recruiting
      • Immunoglobulin G4-Related Disease
      • blood test
      • Barcelona, Spain
        Hospital de la Santa Creu i Sant Pau
      Jun 12, 2023

      Fabry Disease Who Received Lentiviral Gene Therapy in Study

      Enrolling by invitation
      • Fabry Disease
      • Safety and Efficacy Assessments
      • Melbourne, Parkville VIC, Australia
      • +2 more
      Oct 5, 2022

      Food-specific IgG4-guided Elimination Diets Improve Allergy

      Completed
      • Rhinitis, Allergic
      • +4 more
        • Hangzhou, Zhejiang, China
          Second Affiliated Hospital，School of Medicine，Zhejiang Universit
        Sep 25, 2023

        Breast Cancer, Radiation Dermatitis Trial in Toronto (StrataXRT)

        Recruiting
        • Breast Cancer
        • Radiation Dermatitis
        • StrataXRT
        • Toronto, Ontario, Canada
          Odette Cancer Centre, Sunnybrook Health Sciences Centre
        Oct 25, 2022

        Multiple Myeloma Trial in Worldwide (Daratumumab, Lenalidomide, Dexamethasone)

        Active, not recruiting
        Has Results
        • Multiple Myeloma
        • Little Rock, Arkansas
        • +145 more
        Jan 17, 2023

        Determine Immunoglobulin G4 Standards for Cow's Milk and Egg in

        Recruiting
        • Food Allergy in Children
        • Blood collection
        • Paris, France
          Hôpital Necker Enfants malades
        Nov 7, 2022

        IgG4 Related Disease Trial (CM310)

        Not yet recruiting
        • IgG4 Related Disease
        • CM310
        • (no location specified)
        Feb 13, 2023

        Anterior Cruciate Ligament Injuries Trial in China (Reverse drilling technique, Traditional extraction drilling)

        Not yet recruiting
        • Anterior Cruciate Ligament Injuries
        • Reverse drilling technique
        • Traditional extraction drilling
        • Huzhou, Zhejiang, China
        • +5 more
        Aug 9, 2023

        Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Japan (Rituximab (genetical recombination), Placebo)

        Completed
        • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
        • Rituximab (genetical recombination)
        • Placebo
        • Nagoya, Aich, Japan
        • +3 more
        Aug 19, 2021

        Multicenter Observational Study of PSC and IgG4-SC in China

        Recruiting
        • Primary Sclerosing Cholangitis
        • IgG4-related Sclerosing Cholangitis
        • Only observation
        • Shanghai, 上海市, China
          RenJi Hospital
        Jul 18, 2022